|
Michael Weiser M.D. Ph.D. a Director of the Company since 2005 is the founder and co-chairman of Actin Capital LLC and Actin Biomed a New York based healthcare investment firm. Dr. Weiser completed his Ph.D. in Molecular Neurobiology at Cornell University Medical College and received his M.D. from New York University School of Medicine where his also completed a Postdoctoral Fellowship in the Department of Physiology and Neuroscience. Dr. Weiser currently serves on the Board of Manhattan Pharmaceuticals Inc. (OTCBB: MHTT) a publicly traded biotechnology company Hana Biosciences Inc. (HBX) Chelsea Therapeutics International Ltd. (CHTP) VioQuest Pharmaceuticals Inc. (VQPH) Ziopharm Oncology Inc. (ZIOP) and several other privately-held biotechnology companies.
| 